GLP-1 drugs not linked to suicidal thoughts, EU drug regulator finds
European drug regulators have found no significant evidence linking GLP-1 drugs like Ozempic and Wegovy to thoughts of suicide or self-harm. The Food and Drug Administration reached the same conclusion in January.